BCM
SRNE

Bayesian Capital Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bayesian Capital Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-54,700
Closed -$452K – 707
2021
Q1 		$452K Buy
54,700
+24,100
+79% +$199K 0.1% 248
2020
Q4 		$209K Buy
+30,600
New +$209K 0.05% 374